Latest news

Pfizer bets $4.9B on Metsera to rejoin the obesity drug race

Pfizer bets $4.9B on Metsera to rejoin the obesity drug race

Eduardo Longoria
Daily Snap - 22. September 2025

Daily Snap - 22. September 2025

Joachim Eeckhout
Novo Nordisk’s once-weekly diabetes combo drug wins EU support after U.S. setback

Novo Nordisk’s once-weekly diabetes combo drug wins EU support after U.S. setback

Eduardo Longoria
FDA greenlights first-ever Barth syndrome drug after decade-long push

FDA greenlights first-ever Barth syndrome drug after decade-long push

Eduardo Longoria
Daily Snap - 19. September 2025

Daily Snap - 19. September 2025

Joachim Eeckhout
VectorY inks $1.2B deal to boost brain-targeted gene therapy with Shape's delivery tech

VectorY inks $1.2B deal to boost brain-targeted gene therapy with Shape's delivery tech

Eduardo Longoria
Roche bets $2.4B on potential MASH breakthrough with 89bio buy

Roche bets $2.4B on potential MASH breakthrough with 89bio buy

Eduardo Longoria
Daily Snap - 18. September 2025

Daily Snap - 18. September 2025

Joachim Eeckhout
Aditum Bio bets $1B on siRNA breakthrough in heart disease

Aditum Bio bets $1B on siRNA breakthrough in heart disease

Eduardo Longoria
Ollin Biosciences takes aim at Roche with $100M and bold eye drug strategy

Ollin Biosciences takes aim at Roche with $100M and bold eye drug strategy

Eduardo Longoria
Daily Snap - 17. September 2025

Daily Snap - 17. September 2025

Joachim Eeckhout
Genmab axes ADC from $1.8B ProfoundBio buyout over safety concerns

Genmab axes ADC from $1.8B ProfoundBio buyout over safety concerns

Eduardo Longoria
FirstBack
910111213141516
Next Last